MENU
ENTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Entera Bio (ENTX) Earnings Date & Reports
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins... Show more
Industry: #Pharmaceuticals Major
A.I. Advisor
published Earnings
ENTX is expected to report earnings to fall 51.79% to -6 cents per share on November 05
Q3'26
Est.
$-0.07
Q2'26
Missed
by $0.05
Q1'26
Beat
by $0.04
Q4'25
Beat
by $0.05
Q3'25
Beat
by $0.16
The last earnings report on August 10 showed earnings per share of -14 cents, missing the estimate of -9 cents. With 154.39K shares outstanding, the current market capitalization sits at 465.75M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a manufacturer of flu medicines
Industry Biotechnology
Industry
Pharmaceuticals Major
Address
Kiryat Hadassah
Phone
+972 25327151
Employees
22
Web
https://www.enterabio.com